UPC APP 36130/2024
EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
- VitalAire GmbHOperating co.
Representatives- Charlotte Garnitsch-Taylor Wessing
- Christine Kanz-Hoyng Rokh Monegier
Respondents- Roche Diabetes Care GmbHOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Division
- Hamburg LD
- Judges
- —
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Jul 26, 2024
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Hamburg LD | Locked |
At the UPC: Tandem Diabetes Care Group (18 cases)·Roche Group (29 cases)
This dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 11/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023 and 4 more
1 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: Hamburg LD·2024
- 2024-07-26
Summary: The President of the Court of First Instance granted Tandem Diabetes Care's application to change the language of proceedings from German to English (the language in which the patent was granted) in an infringement action brought by Roche Diabetes Care GmbH. The court found that where the balance of interests between the parties was equal (both being international companies), the position of the defendant was the decisive factor.
Show the legal issues (3)
- Change of language of proceedings under Rule 323 RoP
- Balancing of party interests in language decisions
- Position of defendant as decisive factor when interests are equal
- 7E71DC60A502D3174DEB3B591E39C8C5_en.pdf2024-07-26EN